Profiel
Louis Ferrari served as the President, Chief Executive Officer & Director at Savient Pharmaceuticals, Inc. from 2012 to 2013.
He holds an MBA from Adelphi University and an undergraduate degree from Arnold & Marie Schwartz College of Pharmacy & Health Science.
Eerdere bekende functies van Louis Ferrari
| Bedrijven | Functie | Einde |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Algemeen Directeur | 20-06-2013 |
Opleiding van Louis Ferrari
| Adelphi University | Masters Business Admin |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
